CD44 and pancreatic neoplasm: Shah and colleagues [30] from M.D. Anderson showed that pancreatic cancer cell lines that selectively grew in culture media containing therapeutic doses of gemcitabine increased in expression of the stem cell markers CD24, CD44, and ESA.